It is important to increase the diversity of clinical-trial participants because there is growing evidence that gender and ethnicity play important roles in health care outcomes. Not only are certain groups at higher risk for specific diseases, but race and ethnicity play a role in how patients respond to drugs.
Read Increasing Diversity in Clinical Trials Can Save Lives (Op-Ed)
by Dr. Bruce Moskowitz, LiveScience, 01 July 2013.
Our posts tagged All Trials – Pharmaceutical industry.
2 thoughts on “For clinical Trials to succeed, they need more diverse Cohorts of Volunteers”
Reblogged this on Laitom's Blog.